Intimation of closure of trading window of Jenburkt Pharmaceuticals Limited as per the SEBI(PIT) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jenburkt Pharmaceuticals has informed BSE that its trading window will be closed from 1st July 2025 until 48 hours after the company publicly shares its standalone unaudited financial results for the quarter ending 30th June 2025 (Q1 FY26). During this period, designated persons, insiders, connected persons, and their relatives are prohibited from trading in the company's equity shares. The filing is made under SEBI's Prohibition of Insider Trading Regulations, 2015. The company has stated it will separately announce the board meeting date for considering these results. The intimation was signed by Ashish R. Shah, Company Secretary and Compliance Officer.
This is a routine regulatory compliance measure and does not impact shareholders directly. It signals that the Q1 FY26 earnings announcement is approaching, which will be the next key catalyst for the stock. Insiders cannot trade during this blackout, so no insider activity should be expected until at least 48 hours post-results.